Works by Berlin, Jordan D

Results: 31
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10

    A Phase 1b/2 Study of the Bruton Tyrosine Kinase Inhibitor Ibrutinib and the PD-L1 Inhibitor Durvalumab in Patients with Pretreated Solid Tumors.

    Published in:
    Oncology, 2019, v. 97, n. 2, p. 102, doi. 10.1159/000500571
    By:
    • Hong, David;
    • Rasco, Drew;
    • Veeder, Michael;
    • Luke, Jason J.;
    • Chandler, Jason;
    • Balmanoukian, Ani;
    • George, Thomas J.;
    • Munster, Pamela;
    • Berlin, Jordan D.;
    • Gutierrez, Martin;
    • Mita, Alain;
    • Wakelee, Heather;
    • Samakoglu, Selda;
    • Guan, Shanhong;
    • Dimery, Isaiah;
    • Graef, Thorsten;
    • Borazanci, Erkut
    Publication type:
    Article
    11

    An Intergroup Randomized Phase II Study of Bevacizumab or Cetuximab in Combination with Gemcitabine and in Combination with Chemoradiation in Patients with Resected Pancreatic Carcinoma: A Trial of the ECOG-ACRIN Cancer Research Group (E2204).

    Published in:
    Oncology, 2018, v. 94, n. 1, p. 39, doi. 10.1159/000480295
    By:
    • Berlin, Jordan D.;
    • Feng, Yang;
    • Catalano, Paul;
    • Abbruzzese, James L.;
    • Philip, Philip A.;
    • McWilliams, Robert R.;
    • Lowy, Andrew M.;
    • Benson III, Al B.;
    • Blackstock, A. William
    Publication type:
    Article
    12
    13
    14
    15

    First‐in‐human PET imaging and estimated radiation dosimetry of L‐[5‐ 11C]‐glutamine in patients with metastatic colorectal cancer.

    Published in:
    Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.120.261594
    By:
    • Cohen, Allison S.;
    • Grudzinski, Joe;
    • Smith, Gary T.;
    • Peterson, Todd E.;
    • Whisenant, Jennifer G.;
    • Hickman, Tiffany L.;
    • Ciombor, Kristen K.;
    • Cardin, Dana;
    • Eng, Cathy;
    • Goff, Laura W.;
    • Das, Satya;
    • Coffey, Robert J.;
    • Berlin, Jordan D.;
    • Charles Manning, H.
    Publication type:
    Article
    16

    First‐in‐human PET imaging and estimated radiation dosimetry of L‐[5‐<sup>11</sup>C]‐glutamine in patients with metastatic colorectal cancer.

    Published in:
    Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.120.261594
    By:
    • Cohen, Allison S.;
    • Grudzinski, Joe;
    • Smith, Gary T.;
    • Peterson, Todd E.;
    • Whisenant, Jennifer G.;
    • Hickman, Tiffany L.;
    • Ciombor, Kristen K.;
    • Cardin, Dana;
    • Eng, Cathy;
    • Goff, Laura W.;
    • Das, Satya;
    • Coffey, Robert J.;
    • Berlin, Jordan D.;
    • Manning, H. Charles
    Publication type:
    Article
    17

    First‐in‐human PET imaging and estimated radiation dosimetry of L‐[5‐<sup>11</sup>C]‐glutamine in patients with metastatic colorectal cancer.

    Published in:
    Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.120.261594
    By:
    • Cohen, Allison S.;
    • Grudzinski, Joe;
    • Smith, Gary T.;
    • Peterson, Todd E.;
    • Whisenant, Jennifer G.;
    • Hickman, Tiffany L.;
    • Ciombor, Kristen K.;
    • Cardin, Dana;
    • Eng, Cathy;
    • Goff, Laura W.;
    • Das, Satya;
    • Coffey, Robert J.;
    • Berlin, Jordan D.;
    • Manning, H. Charles
    Publication type:
    Article
    18
    19
    20
    21
    22

    A Phase Ib Dose-Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Cobimetinib and Duligotuzumab in Patients with Previously Treated Locally Advanced or Metastatic Cancers with Mutant KRAS.

    Published in:
    Oncologist, 2017, v. 22, n. 9, p. 1024, doi. 10.1634/theoncologist.2017-0175
    By:
    • Lieu, Christopher H.;
    • Hidalgo, Manuel;
    • Berlin, Jordan D.;
    • Ko, Andrew H.;
    • Cervantes, Andres;
    • LoRusso, Patricia;
    • Gerber, David E.;
    • Eder, J. Paul;
    • Eckhardt, S. Gail;
    • Kapp, Amy V.;
    • Tsuhako, Amy;
    • McCall, Bruce;
    • Pirzkall, Andrea;
    • Uyei, Anne;
    • Tabernero, Josep
    Publication type:
    Article
    23

    Academic Cancer Center Phase I Program Development.

    Published in:
    Oncologist, 2017, v. 22, n. 4, p. 369, doi. 10.1634/theoncologist.2016-0409
    By:
    • Frankel, Arthur E.;
    • Flaherty, Keith T.;
    • Weiner, George J.;
    • Chen, Robert;
    • Azad, Nilofer S.;
    • Pishvaian, Michael J.;
    • Thompson, John A.;
    • Taylor, Matthew H.;
    • Mahadevan, Daruka;
    • Lockhart, A. Craig;
    • Vaishampayan, Ulka N.;
    • Berlin, Jordan D.;
    • Smith, David C.;
    • Sarantopoulos, John;
    • Riese, Matthew;
    • Saleh, Mansoor N.;
    • Ahn, Chul;
    • Frenkel, Eugene P.
    Publication type:
    Article
    24

    Enabling a Genetically Informed Approach to Cancer Medicine: A Retrospective Evaluation of the Impact of Comprehensive Tumor Profiling Using a Targeted Next-Generation Sequencing Panel.

    Published in:
    Oncologist, 2014, v. 19, n. 6, p. 616, doi. 10.1634/theoncologist.2014-0011
    By:
    • Johnson, Douglas B.;
    • Dahlman, Kimberly H.;
    • Knol, Jared;
    • Gilbert, Jill;
    • Puzanov, Igor;
    • Means‐Powell, Julie;
    • Balko, Justin M.;
    • Lovly, Christine M.;
    • Murphy, Barbara A.;
    • Goff, Laura W.;
    • Abramson, Vandana G.;
    • Crispens, Marta A.;
    • Mayer, Ingrid A.;
    • Berlin, Jordan D.;
    • Horn, Leora;
    • Keedy, Vicki L.;
    • Reddy, Nishitha M.;
    • Arteaga, Carlos L.;
    • Sosman, Jeffrey A.;
    • Pao, William
    Publication type:
    Article
    25
    26
    27
    28
    29
    30
    31